-+ 0.00%
-+ 0.00%
-+ 0.00%

APTEVO THERAPEUTICS - RAINIER TRIAL TO CONCLUDE BY YEAR-END; PHASE 2 INITIATION ANTICIPATED IN H1 2027 - SEC FILING

Reuters·10/26/2026 12:16:33

Please log in to view news